Organization Announcements

::::::

 
 

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.
 
 
Airfinity [to 12 Feb 2022]
https://www.airfinity.com/insights
INSIGHTS & COMPANY NEWS
No new digest content identified.
 
 
Paul G. Allen Frontiers Group [to 12 Feb 2022]
https://alleninstitute.org/news-press/
News
Press Release
The Paul G. Allen Frontiers Group announces 23 new Allen Distinguished Investigators
February 9, 2022
$15.5M in research funding will support cutting-edge projects in mammalian synthetic biology, the neuroscience of under-studied animals, and tiny proteins involved in immunity
 
 
BMGF – Gates Foundation [to 12 Feb 2022]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
No new digest content identified.
 
 
Bill & Melinda Gates Medical Research Institute [to 12 Feb 2022]
https://www.gatesmri.org/news
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X [to 12 Feb 2022]
https://carb-x.org/
News
No new digest content identified.
 
 
Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 12 Feb 2022]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Informed Consent: A Monthly Review – February 2022 is now posted here
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: Statement on ICF [Informed Consent Form] Posting for Clinical Trials Involving Gene Editing/Gene Therapies – Invitation to Endorse
 
 
CEPI – Coalition for Epidemic Preparedness Innovations [to 12 Feb 2022]
http://cepi.net/
Latest News
CEPI, Shanghai Zerun Biotech and Walvax Biotech expand collaboration to develop COVID-19 multi-variant vaccine
OSLO, Norway, SHANGHAI and KUNMING, China; 8 February 2022: CEPI, the Coalition for Epidemic Preparedness Innovations, today announced that it will expand its collaboration with Shanghai Zerun Biotechnology Co., Ltd. (Zerun Bio) and its parent company Walvax Biotechnology Co., Ltd. (Walvax), a public company listed on the Shenzhen Stock Exchange (300142.SZ) to advance the development of a COVID-19 variant vaccine. CEPI will invest up to an additional USD$8.15 million to support a Phase I/II clinical trial in Mali which will evaluate the safety and immunogenicity of Zerun Bio’s prototype and multi-variant vaccine candidates. This will be the first clinical trial of the multi-variant vaccine, which has the potential to provide protection against a broad range of COVID-19 variants.
Including this latest funding, CEPI has now committed up to USD$25.1 million to this vaccine development partnership to support preclinical studies, early-stage clinical trials, process optimization and manufacturing scale-up of prototype and multi-variant vaccines…
 
 
DARPA – Defense Advanced Research Projects Agency [U.S.] [to 12 Feb 2022
https://www.darpa.mil/news
News
No new digest content identified.
 
 
Duke Global Health Innovation Center [to 12 Feb 2022]
https://dukeghic.org/
Our Blog
No new digest content identified.
 
 
EDCTP [to 12 Feb 2022]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
News
No new digest content identified.
 
 
Emory Vaccine Center [to 12 Feb 2022]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.
 
 
European Vaccine Initiative [to 12 Feb 2022]
http://www.euvaccine.eu/
Latest News, Events
No new digest content identified.
 
 
Evidence Aid [to 12 Feb 2022]
Evidence Aid aims to save lives and livelihoods in disasters by providing decision-makers with the best available evidence and by championing its use.
http://www.evidenceaid.org/
New Resources
Interventions to prevent persistent post‐COVID‐19 olfactory dysfunction (search on 16 December 2020) Added February 11, 2022

 
 

COVID‐19 vaccination intention in the first year of the pandemic (search up to 31 December 2020) Added February 7, 2022
 
 
Fondation Merieux [to 12 Feb 2022]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.
 
 
Gavi [to 12 Feb 2022]
https://www.gavi.org/
News Releases
No new digest content identified.

GHIT Fund [to 12 Feb 2022]
https://www.ghitfund.org/newsroom/press
No new digest content identified.
 
 
Global Fund [to 12 Feb 2022]
https://www.theglobalfund.org/en/news/
News & Stories
Call for Applications for New Global Fund Independent Evaluation Panel
11 February 2022
The Global Fund’s independent evaluation function is being transformed in order to strengthen accountability and learning, based on the results of independent evaluations. The objective is to ensure that evaluations are relevant, timely and of high quality, driving us closer to achieving our goal of ending HIV, TB and malaria as epidemics.
The Global Fund is inviting applications for its new Independent Evaluation Panel (IEP), a body of around ten members that will replace the current Technical Evaluation Reference Group (TERG) at the end of 2022…
 
 
Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 12 Feb 2022]
https://www.glopid-r.org/news/
News
GloPID-R and UK DHSC organise funders’ roundtable to strengthen the clinical trials ecosystem
11/02/2022
Funders play a critical role in clinical trials, representing a major force in improving trial coordination during global health emergencies… The roundtable highlighted that sustained coordination, flexibility, efficiency and the translation of findings into policy are essential to promote high-quality clinical research during and between global health emergencies. Also, for global research collaboration to be achieved, research capacity must be strengthened in low- and middle-income countries. The Forum demonstrated the key role of funders in achieving this…
 
 
Hilleman Laboratories [to 12 Feb 2022]
http://www.hillemanlabs.org/
News & Insights
HILLEMAN VACCINES & BIOLOGICS SYMPOSIUM – 23 February 2022
agenda
register
 
 
HHMI – Howard Hughes Medical Institute [to 12 Feb 2022]
https://www.hhmi.org/news
Press Room
Research Feb 8 2022
Nasal Spray Booster Keeps COVID-19 at Bay
In mice, a vaccination strategy that uses an mRNA coronavirus vaccine injection followed by a nasal spray booster generates immune protection in the airways.
 
 
Human Vaccines Project [to 12 Feb 2022]
http://www.humanvaccinesproject.org/
News
No new digest content identified.
 
 
IAVI [to 12 Feb 2022]
https://www.iavi.org/
Latest News
No new digest content identified.
 
 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 
 
IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.
 
 
IFRC [to 12 Feb 2022]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
No new digest content identified.

 
 
Institut Pasteur [to 12 Feb 2022]
https://www.pasteur.fr/en/press-area
Press Documents
No new digest content identified.
 
 
IOM / International Organization for Migration [to 12 Feb 2022]
http://www.iom.int/press-room/press-releases
News – Selected
News
11 Feb 2022
New Study Highlights Social Media’s Key Role in COVID-19 Vaccine Uptake for Migrants
Berlin – Governments could close COVID-19 vaccination gaps by breaking down language barriers and giving migrants easier access to information particularly through social media, according to a study published today by the International Organization for Migration (IOM) and the University of Potsdam.
Studies from several countries in the US and Europe, including Germany, suggest that vaccination rates are lower among migrant communities compared to the general population. Gaps may vary by country and group but a recent study by the Robert Koch Institute in Germany revealed that the vaccination rate among migrants is 8 per cent lower compared to the native-born population. The study argues that such vaccination gaps may be linked to language barriers, socioeconomic status, and misinformation among migrant communities.
IOM’s Global Migration Data Analysis Centre (GMDAC) and the University of Potsdam tested the effect of language and trust barriers in Germany via a social media campaign in their study, “Promoting COVID-19 vaccination uptake among migrant communities on social media – Evidence from Germany’’.
“More evidence on the interlinkage between migration and health is urgently needed,” said GMDAC Director Frank Laczko. “Many countries around the world have large migrant populations, yet many of them do not consider the needs of migrants sufficiently in their vaccination programmes.”
Expensive national campaigns to boost vaccine uptake using print, TV, and radio often neglect social media. The results of the study show how specific groups can be reached more effectively and at low cost…

ISC / International Science Council [to 12 Feb 2022]
https://council.science/current/
ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.
News Blogs Podcasts
Blogs
Celebrating women and girls who are leading the way in science and innovation – 11.02.2022
Join us in celebrating today the 7th International Day of Women and Girls in Science, a day dedicated to remarkable women and girls around the world who are inventing the future and making the world a better place through the power of science. Female scientists who go beyond any barrier, forge new scientific paths and are at the forefront of achieving a much-needed gender equality in science…
 
 
IVAC [to 12 Feb 2022]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
IVAC and VALUE Baltimore Project Launch COVID-19 Information Compendium
February 2022
The VALUE (Vaccine Acceptance & Access Live in Unity, Education, and Engagement) Baltimore Project, which aims to improve COVID-19 vaccine acceptance in Baltimore City, has created a new resource for anyone seeking up-to-date information about COVID-19. This free resource has six topic areas: COVID-19 Illness General Vaccine Information COVID-19 Vaccines COVID-19 Vaccine Policy COVID-19 Vaccines […]
 
 
IVI [to 12 Feb 2022]
http://www.ivi.int/
IVI News & Announcements
No new digest content identified.
 
 
Johns Hopkins Center for Health Security [to 12 Feb 2022]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
Applications Now Open for the Emerging Leaders in Biosecurity Fellowship Class of 2022
February 9, 2022
 
 
MSF/Médecins Sans Frontières [to 12 Feb 2022]
http://www.msf.org/
Latest [Selected Announcements]
No new digest content identified.
 
 
National Academy of Sciences – USA [to 12 Feb 2022]
http://www.nasonline.org/news-and-multimedia/
News
No new digest content identified.
 
 
National Vaccine Program Office – U.S. HHS [to 12 Feb 2022]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
No new digest content identified.
 
 
NIH [to 12 Feb 2022]
http://www.nih.gov/news-events/news-releases
News Releases
NIH-funded study suggests COVID-19 increases risk of pregnancy complications
Mo nday, February 7, 2022
Pregnant women with COVID-19 appear to be at greater risk for common pregnancy complications — in addition to health risks from the virus — than pregnant women without COVID-19, suggests a study funded by the National Institutes of Health.
 
 
OECD [to 12 Feb 2022]
http://www.oecd.org/newsroom/publicationsdocuments/bydate/
Newsroom
No new digest content identified.
 
 
PATH [to 12 Feb 2022]
https://www.path.org/media-center/
Press Releases
PATH Board of Directors announces annual officer elections
February 10, 2022 by PATH
PATH’s Board of Directors is pleased to announce the appointment of new officers following its annual officer elections in December of 2021.
Beth Galetti, Senior Vice President of People Experience and Technology at Amazon, has been named Board Chair. Most recently, Galetti held the Vice Chair position as well as seats on the Executive and Audit Committees, and she has served on the PATH Board since 2018. At Amazon, Galetti leads a team that oversees the recruitment, growth, development, and support of more than one million employees in over 50 countries…
 
 
Sabin Vaccine Institute [to 12 Feb 2022]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.
 
 
UNAIDS [to 12 Feb 2022]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
9 February 2022
Networks led by young people in Asia and the Pacific find ways to adapt to COVID-19 and deal with uncertain futures

UNHCR Office of the United Nations High Commissioner for Refugees [to 12 Feb 2022]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
No new digest content identified.

UNICEF [to 12 Feb 2022]
https://www.unicef.org/media/press-releases
Press Releases, News Notes, Statements [Selected]
Press release
02/09/2022
ACT-Accelerator calls for fair share-based financing of US$ 23 billion to end pandemic as global emergency in 2022

Remarks
02/08/2022
Remarks by UNICEF Executive Director Catherine M. Russell at the opening of the UNICEF Executive Board
As prepared for delivery

Unitaid [to 12 Feb 2022]
https://unitaid.org/
Featured News
No new digest content identified.
 
 
USAID [to 12 Feb 2022]
https://www.usaid.gov/news-information/press-releases/2021
Selected Press Releases, Statements, Announcements
News
No new digest content identified.
 
 
Vaccine Equity Cooperative [nee Initiative] [to 12 Feb 2022]
https://vaccineequitycooperative.org/news/
News
No new digest content identified.
 
 
Vaccination Acceptance & Demand Initiative [Sabin) [to 12 Feb 2022]
https://www.vaccineacceptance.org/
Announcements
No new digest content identified.
 
 
Vaccine Confidence Project [to 12 Feb 2022]
http://www.vaccineconfidence.org/
News, Research and Reports
No new digest content identified.
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia [to 12 Feb 2022]
http://www.chop.edu/centers-programs/vaccine-education-center
News
No new digest content identified.
 
 
Wellcome Trust [to 12 Feb 2022]
https://wellcome.ac.uk/news
News. Opinion, Reports
No new digest content identified.
 
 
The Wistar Institute [to 12 Feb 2022]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.
 
 
WFPHA: World Federation of Public Health Associations [to 12 Feb 2022]
https://www.wfpha.org/
Latest News – Blog
Event
What Is Leadership in a Pandemic?
Feb 7, 2022
…On February 16, 2022, at 13:00 – 14:30 (CET), global public health leaders, working within the framework of the WFPHA, will discuss concrete actions to promote equity, public health leadership and global coordination to address pressing global health challenges, including the COVID-19 pandemic and other health threats. Register
 
 
World Bank [to 12 Feb 2022]
http://www.worldbank.org/en/news/all
Selected News, Announcements
Solid Waste Management
Context Around the world, waste generation rates are rising. In 2016, the worlds’ cities generated 2.01 billion tons of solid waste, amounting to a footprint of 0.74 kilograms per person per…
Date: February 11, 2022 Type: Brief

Greater and More Diverse Participation in Global Trade is Key to Achieving Africa’s Economic Transformation, says New World Bank Book
ACCRA, February 10, 2022 – African countries must expand and diversify their participation in international trade and global value chains to reduce poverty on a large scale and transform their economies…
Date: February 10, 2022 Type: Press Release

The World Bank’s Blue Economy Program and PROBLUE: Supporting integrated and sustainable economic development in healthy oceans
What is PROBLUE? PROBLUE is an Umbrella Multi-Donor Trust Fund (MDTF) administered by the World Bank, designed to help countries chart a course towards a blue economy approach. A blue economy refers to…
Date: February 10, 2022 Type: Brief

New World Bank Report Identifies Reforms to Improve Public Expenditure for Human Capital
KATHMANDU, February 9, 2022 – Nepal has made significant progress in human capital development, though key challenges remain in the health, education, and social protection sectors, which have been…
Date: February 09, 2022 Type: Press Release

COVID-19 Pandemic Leads to Innovations in Education in Saudi Arabia
Six million children benefited from Saudi Arabia’s innovative distance learning platform “Madrasati” RIYADH, February 8, 2022 — School closures due to the pandemic led to 6 million children being part…
Date: February 08, 2022 Type: Press Release

World Organisation for Animal Health (OIE) [to 12 Feb 2022]
https://www.oie.int/en/media/news/
Press Releases, Statements
Digital transformation and the OIE Observatory: A synergic approach
Editor’s Choice
9 February 2022
Digital transformation is identified as a key objective in the World Organisation for Animal Health’s (OIE’s) Seventh Strategic Plan, and is an important response to the need to become a more modern and agile organisation. This is a vital shift in view of the increasing use of information technologies to support regulation for animal health, animal welfare and veterinary public health…
At present, the OIE is defining its expectations of data stewardship through the establishment of a data governance framework. These expectations include demonstrating responsible management of data and enhancing access to data for Members while respecting concerns for privacy and intellectual property. This work will provide essential organisation-wide rules and processes while also determining the development and direction of each of our key information systems, including those contributed to regularly by OIE Members..
 
 
WTO – World Trade Organisation [to 12 Feb 2022]
http://www.wto.org/english/news_e/news_e.htm
WTO News and Events
Workshop looks into practical aspects of supporting equitable access to COVID-19 vaccines
11 February 2022
Over 250 representatives from WTO members and observers participated on 11 February in a technical workshop focused on the practical aspects of COVID-19 vaccine research and development (R&D), manufacturing, regulatory approval, distribution, and coordination of vaccination campaigns. WTO Deputy Director-General Anabel González hosted the event…The video of the session is available here. The programme, speakers’ biographies and background materials are available here.

Selected slides from meeting:

WTO members, international organizations outline Aid for Trade activities amid COVID-19
8 February 2022
An overview of recent Aid for Trade activities was given by WTO members, international financial institutions and observer organisations at a session of the Committee on Trade and Development on 8 February dedicated to the Aid for Trade initiative. A workshop organized by the Committee on 7 February explored how the COVID-19 pandemic has accelerated the shift towards the digital economy and the constraints that developing countries face.

DDG Ellard: Multilateralism is the solution to challenges of global commons, unilateralism
7 February 2022
Deputy Director-General Angela Ellard delivered a lecture to the US National War College on 7 February in which she discussed economic multilateralism as a potent instrument of economic power. She addressed the historical context and basic principles of the WTO as well as the modern challenges facing the organization and the multilateral trading system.

 

::::::
 
 
ARM [Alliance for Regenerative Medicine] [to 12 Feb 2022]
https://alliancerm.org/press-releases/
Selected Press Releases
No new digest content identified.
 
 
BIO [to 12 Feb 2022]
https://www.bio.org/press-releases
Press Releases, Letters, Testimony, Comments [Selected]
No new digest content identified.
 
 
DCVMN – Developing Country Vaccine Manufacturers Network [to 12 Feb 2022]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.
 
 
ICBA – International Council of Biotechnology Associations [to 12 Feb 2022]
https://internationalbiotech.org/news/
News
Website in “maintenance mode”
 
 
IFPMA [to 12 Feb 2022]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
Position paper – Use of electronic labeling
07 February 2022
“E-labeling will increasingly play a role in facilitating fast deployment of product information and facilitate patient understanding and adherence.

 
 
 
International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
IGBA establishes a CEO Advisory Committee (February 2022, Committee updated)
The International Generic and Biosimilar medicines Association (IGBA) announced today that it has established a CEO Advisory Committee composed of fourteen leading multinational companies from Canada, Europe, India, Israel, Japan and the United States.
Committee members are:
Chirag Patel, President and Co-Chief Executive Officer – Amneal Pharmaceuticals Inc.
Jeff Watson, President and Chief Executive Officer – Apotex Inc.
Pankaj Patel, Chairman – Cadila Healthcare Ltd.
Samina Hamied, Executive Vice-Chairperson – Cipla Ltd.
Satish Reddy, Chairman – Dr. Reddy’s Laboratories Ltd.
Lucas Sigman, Chief Executive Officer – Insud Pharma S.L.
Vinita Gupta, Chief Executive Officer – Lupin Ltd.
Markus Sieger, Chief Executive Officer – Polpharma Group
Richard Saynor, Chief Executive Officer – Sandoz AG
Peter Goldschmidt, Chief Executive Officer and Chairman Executive Board – STADA Arzneimittel AG
Dilip Shanghvi, Managing Director – Sun Pharmaceutical Industries Ltd.
Kåre Schultz, President and Chief Executive Officer – Teva Pharmaceuticals Industries Ltd.
David Peix, Chief Executive Officer – Towa Pharma International Holdings S.L.
Michael Goettler, Chief Executive Officer – Viatris Inc.
This Committee provides a forum for industry leaders to discuss broad, strategic issues, and to engage and position the industry on a range of critical policy issues…
 
 
International Alliance of Patients’ Organizations – IAPO [to 12 Feb 2022]
https://www.iapo.org.uk/news/topic/6
Press and media [Selected]
No new digest content identified.
 
 
PhRMA [to 12 Feb 2022]
http://www.phrma.org/
Latest News [Selected]
Takeda’s Ramona Sequeira Becomes Board Chair of PhRMA
Feb 9, 2022
The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Ramona Sequeira, President of Takeda’s U.S. Business Unit and Global Portfolio Commercialization, has assumed the role of chair of the PhRMA Board of Directors.

Journal Watch

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

The impact of COVID-19 and associated measures on health, police, and non-government organisation service utilisation related to violence against women and children

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 12 Feb 2022)

 

The impact of COVID-19 and associated measures on health, police, and non-government organisation service utilisation related to violence against women and children
Globally, concerns have been raised that the priority implementation of public health measures in response to COVID-19 may have unintended negative impacts on a variety of other health and wellbeing factors, i…
Authors: Nadia Butler, Zara Quigg, Isabelle Pearson, Zhamin Yelgezekova, Aasa Nihlén, Mark A. Bellis, Yongjie Yon, Jonathon Passmore, Isabel Yordi Aguirre and Heidi Stöckl
Citation: BMC Public Health 2022 22:288
Content type: Research
Published on: 12 February 2022

Global research alliance in infectious disease: a collaborative effort to combat infectious diseases through dissemination of portable sequencing

BMC Research Notes
http://www.biomedcentral.com/bmcresnotes/content
(Accessed 12 Feb 2022)

 

Global research alliance in infectious disease: a collaborative effort to combat infectious diseases through dissemination of portable sequencing
To disseminate the portable sequencer MinION in developing countries for the main purpose of battling infectious diseases, we found a consortium called Global Research Alliance in Infectious Diseases (GRAID). …
Authors: Lucky R. Runtuwene, Nuankanya Sathirapongsasuti, Raweewan Srisawat, Narumon Komalamisra, Josef S. B. Tuda, Arthur E. Mongan, Gabriel O. Aboge, Victoria Shabardina, Wojciech Makalowski, Dela Ria Nesti, Wayan T. Artama, Lan Anh Nguyen-Thi, Kiew-Lian Wan, Byoung-Kuk Na, William Hall, Arnab Pain…
Citation: BMC Research Notes 2022 15:44
Content type: Research note
Published on: 12 February 2022

Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days

Contemporary Clinical Trials
Volume 113 February 2022
https://www.sciencedirect.com/journal/contemporary-clinical-trials/vol/113/suppl/C

 

Research article Open access
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days
Erin K. McCreary, J. Ryan Bariola, Tami Minnier, Richard J. Wadas, … Derek C. Angus
Article 106652

Austria: General COVID-19 Vaccine Mandate Enters into Force

Global Legal Monitor – Library of Congress/USA
https://www.loc.gov/collections/global-legal-monitor/
[Accessed 12 Feb 2022]

 

Article
Austria: General COVID-19 Vaccine Mandate Enters into Force
On February 5, 2022, a general COVID-19 vaccine mandate entered into force in Austria for every Austrian resident 18 years or older. No direct coercion will be used to enforce it, meaning no one will be imprisoned for noncompliance; only administrative fines will be imposed. The COVID-19 Mandatory Vaccination Act (Act) will be automatically repealed … Continue reading “Austria: General COVID-19 Vaccine Mandate Enters…
Contributor: Gesley, Jenny
Date: 2022-02-10

Vaccine nationalism will persist: global public goods need effective engagement of global citizens

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 12 Feb 2022]

 

Vaccine nationalism will persist: global public goods need effective engagement of global citizens
Authors: Stuart J. Peacock
Content type: Debate
12 February 2022
Abstract
Covid-19 presents a unique opportunity to transform democratic engagement in the governance of global public goods. In this paper, I describe a global public goods framework and how it relates to Covid-19 vaccines, and summarize some of the global responses to Covid-19. I discuss some of the global threats to health and prosperity posed by the inequitable distribution of vaccines, and propose transformative thinking to democratically engage citizens in the governance of global public goods. In recent years, public-private partnerships and philanthropic organizations have successfully stepped in to help international organizations like the UN and WHO provide global public goods, but they are not democratically elected or publicly accountable. Global public goods are critical to addressing Covid-19, future pandemic preparedness, global health policy, health equity, and the unfolding climate crisis. To make us more resistant and resilient to future global health crises we need transformative thinking to democratically engage global citizens. We need to lay the foundations for a ‘global social contract’ on global public goods.

Public finance of universal routine childhood immunization in India: district-level cost estimates

Health Policy and Planning
Volume 37, Issue 2, February 2022
https://academic.oup.com/heapol/issue/37/2

 

ORIGINAL ARTICLES
Public finance of universal routine childhood immunization in India: district-level cost estimates
Emily Schueller, Arindam Nandi, Amit Summan, Susmita Chatterjee, Arindam Ray
Health Policy and Planning, Volume 37, Issue 2, February 2022, Pages 200–208, https://doi.org/10.1093/heapol/czab114

COVID-19 Preparedness and Response Plans from 106 countries: a review from a health systems resilience perspective

Health Policy and Planning
Volume 37, Issue 2, February 2022
https://academic.oup.com/heapol/issue/37/2

 

COVID-19 Preparedness and Response Plans from 106 countries: a review from a health systems resilience perspective
Saqif Mustafa, Yu Zhang, Zandile Zibwowa, Redda Seifeldin, Louis Ako-Egbe
Health Policy and Planning, Volume 37, Issue 2, February 2022, Pages 255–268, https://doi.org/10.1093/heapol/czab089

Understanding the complexity of demand-side determinants on vaccine uptake in sub-Saharan Africa

Health Policy and Planning
Volume 37, Issue 2, February 2022
https://academic.oup.com/heapol/issue/37/2

 

REVIEW
Understanding the complexity of demand-side determinants on vaccine uptake in sub-Saharan Africa
Phylisha G van Heemskerken, Catherine J Decouttere, Henk Broekhuizen, Nico J Vandaele
Health Policy and Planning, Volume 37, Issue 2, February 2022, Pages 281–291, https://doi.org/10.1093/heapol/czab139

SARS-CoV-2 infections in children: Understanding diverse outcomes

Immunity
Feb 08, 2022 Volume 55 Issue 2 p185-376
https://www.cell.com/immunity/current

 

Perspective
SARS-CoV-2 infections in children: Understanding diverse outcomes
Petter Brodin
Open Access
Brodin summarizes the current understanding of immune responses to SARS-CoV-2 infections in children and the possible explanations for the overall milder COVID-19 disease in young versus older individuals. To explain the combined observations to date, Brodin proposes an energy allocation perspective to explain mild disease, viral dynamics, and MIS-C in children and young people.

Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19

JAMA
February 8, 2022, Vol 327, No. 6, Pages 503-597
https://jamanetwork.com/journals/jama/currentissue

 

Caring for the Critically Ill Patient
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19
Hidde Heesakkers, MD; Johannes G. van der Hoeven, MD, PhD; Stijn Corsten, MD; et al.
free access has active quiz
JAMA. 2022;327(6):559-565. doi:10.1001/jama.2022.0040
This exploratory prospective cohort study assesses the occurrence of physical, mental, and cognitive symptoms among ICU patients in the Netherlands who survived COVID-19 at 1 year following hospitalization.

Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves

JAMA
February 8, 2022, Vol 327, No. 6, Pages 503-597
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves
Caroline Maslo, MD, PhD; Richard Friedland, MD, BVSc; Mande Toubkin, RN, RM, Rpaeds; et al.
free access has active quiz
JAMA. 2022;327(6):583-584. doi:10.1001/jama.2021.24868
This study describes the characteristics and clinical outcomes of patients hospitalized in South Africa during the Omicron wave compared with the same variables from earlier COVID-19 waves.

US Insurer Spending on Ivermectin Prescriptions for COVID-19

JAMA
February 8, 2022, Vol 327, No. 6, Pages 503-597
https://jamanetwork.com/journals/jama/currentissue

 

US Insurer Spending on Ivermectin Prescriptions for COVID-19
Kao-Ping Chua, MD, PhD; Rena M. Conti, PhD; Nora V. Becker, MD, PhD
free access has active quiz
JAMA. 2022;327(6):584-587. doi:10.1001/jama.2021.24352
This study examines insurer coverage of ivermectin prescriptions for COVID-19 in the US.

Association of Discrimination and Health Care Experiences With Incomplete Infant Vaccination During COVID-19

JAMA Pediatrics
February 2022, Vol 176, No. 2, Pages 115-212
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

Research Letter
Association of Discrimination and Health Care Experiences With Incomplete Infant Vaccination During COVID-19
Heidi Preis, PhD; Marci Lobel, PhD; Brittain Mahaffey, PhD; et al.
free access has active quiz
JAMA Pediatr. 2022;176(2):196-198. doi:10.1001/jamapediatrics.2021.4710
This observational analysis explores how the COVID-19 pandemic contributed to a decrease in infant vaccinations.

Intention to Vaccinate Children Against COVID-19 Among Vaccinated and Unvaccinated US Parents

JAMA Pediatrics
February 2022, Vol 176, No. 2, Pages 115-212
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

Intention to Vaccinate Children Against COVID-19 Among Vaccinated and Unvaccinated US Parents
Madhura S. Rane, PhD; McKaylee M. Robertson, PhD; Drew A. Westmoreland, PhD; et al.
free access has active quiz
JAMA Pediatr. 2022;176(2):201-203. doi:10.1001/jamapediatrics.2021.5153
This study examines parental intention to vaccinate children against COVID-19 and related sociodemographic factors in a national sample of US parents.

State Laws Permitting Adolescent Consent to Human Papillomavirus Vaccination and Rates of Immunization

JAMA Pediatrics
February 2022, Vol 176, No. 2, Pages 115-212
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

State Laws Permitting Adolescent Consent to Human Papillomavirus Vaccination and Rates of Immunization
Ashlynn R. Torres, BA; Nicholaus P. Johnson, MPH; Mallory K. Ellingson, MPH; et al.
JAMA Pediatr. 2022;176(2):203-205. doi:10.1001/jamapediatrics.2021.4591
This national cohort study examines National Immunization Survey–Teen to assess the association of adolescents’ ability to consent to human papillomavirus vaccination without parental involvement with vaccination rates.

A Multilevel Intervention to Increase HPV Vaccination among Asian American Adolescents

Journal of Community Health
Volume 47, issue 1, February 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-1

 

Articles
A Multilevel Intervention to Increase HPV Vaccination among Asian American Adolescents
Authors (first, second and last of 9)
Grace X. Ma, Lin Zhu, Min Qi Wang
Content type: Original Paper
Open Access
Published: 07 July 2021
Pages: 9 – 16

Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine Hesitancy

Journal of Community Health
Volume 47, issue 1, February 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-1

 

Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine Hesitancy
Authors (first, second and last of 5)
Kaidi He, Wendy J. Mack, Vikram Anand
Content type: Original Paper
Published: 23 July 2021
Pages: 39 – 52

Increasing Human Papillomavirus Vaccination in a Federally Qualified Health Center Organization Using a Systems-Based Intervention Integrating EHR and Statewide Immunization Information System

Journal of Community Health
Volume 47, issue 1, February 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-1

 

Increasing Human Papillomavirus Vaccination in a Federally Qualified Health Center Organization Using a Systems-Based Intervention Integrating EHR and Statewide Immunization Information System
Authors (first, second and last of 7)
Debra M. Vinci, Jessica Ryan, Rebecca McClain
Content type: Original Paper
Open Access
Published: 31 July 2021
Pages: 53 – 62

Outcomes from the Use of Targeted Interventions to Increase Meningococcal Vaccination Rates in a Pediatric Clinic

Journal of Community Health
Volume 47, issue 1, February 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-1

 

Outcomes from the Use of Targeted Interventions to Increase Meningococcal Vaccination Rates in a Pediatric Clinic
Authors (first, second and last of 5)
Lindsay Podraza, Jayan Vasudevan, Meera Varman
Content type: Original Paper
Published: 13 August 2021
Pages: 87 – 93

Offline: Complacency threatens progress against COVID-19

The Lancet
Feb 12, 2022 Volume 399 Number 10325 p605-694
https://www.thelancet.com/journals/lancet/issue/current

 

Comment
Offline: Complacency threatens progress against COVID-19
Richard Horton
Hans Kluge, WHO’s Regional Director for Europe, has been reported as saying that European nations could soon be entering a “long period of tranquillity” as the pandemic abates. Pointing out that mortality from COVID-19 seemed to be plateauing, he suggested the continent was approaching a “plausible endgame” and an “enduring peace”. As WHO’s chief spokesperson for the 53 countries that make up his regional responsibility, Kluge was no doubt seeking to strike an optimistic and encouraging note. But it is disappointing that he took such a narrow geographical perspective about a global pandemic. His words promote a false reassurance that could breed complacency, even conceit…

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet
Feb 12, 2022 Volume 399 Number 10325 p605-694
https://www.thelancet.com/journals/lancet/issue/current

 

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Open Access

Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta

Nature
Volume 602 Issue 7896, 10 February 2022
https://www.nature.com/nature/volumes/602/issues/7896

 

Article | 22 December 2021 | Open Access
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
The Alpha variant of SARS-CoV-2 outcompetes progenitor SARS-CoV-2 in upper respiratory tract replication competition in vivo.
Lorenz Ulrich, Nico Joel Halwe, Charaf Benarafa

Local and systemic responses to SARS-CoV-2 infection in children and adults

Nature
Volume 602 Issue 7896, 10 February 2022
https://www.nature.com/nature/volumes/602/issues/7896

 

Article | 22 December 2021 | Open Access
Local and systemic responses to SARS-CoV-2 infection in children and adults
Mechanisms explaining the milder clinical syndrome that is observed in children with SARS-CoV-2 infection.
Masahiro Yoshida, Kaylee B. Worlock, Kerstin B. Meyer

Our genes, our microbes

Nature Genetics
Volume 54 Issue 2, February 2022
https://www.nature.com/ng/volumes/54/issues/2

 

Editorial | 11 February 2022
Our genes, our microbes
In recent years, large-scale genomic studies have been performed in attempts to determine how genetic variation in the human host influences the gut microbiome. As microbiome traits are very heterogeneous, new analytical approaches are needed to move this field forward. By using genetic tools, there is a huge opportunity to enrich our understanding of the complex link between humans and our intimately associated microbial species.

Challenges and future directions for studying effects of host genetics on the gut microbiome

Nature Genetics
Volume 54 Issue 2, February 2022
https://www.nature.com/ng/volumes/54/issues/2

 

Perspective | 03 February 2022
Challenges and future directions for studying effects of host genetics on the gut microbiome
This Perspective discusses the analytical issues concerning heterogeneity and power encountered in microbial genome-wide association studies and highlights potential future directions for genetic analysis of the microbiome.
Serena Sanna, Alexander Kurilshikov, Alexandra Zhernakova

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

New England Journal of Medicine
February 10, 2022 Vol. 386 No. 6
https://www.nejm.org/toc/nejm/medical-journal

 

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico L.M. Dunkle and Others
NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (Covid-19) in phase 2b–3 trials in the United Kingdom and South Africa, but its efficacy had not yet been tested in North America.

Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 12 Feb 2022)

 

Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland
Lauri Sääksvuori, Cornelia Betsch, Hanna Nohynek, Heini Salo, Jonas Sivelä, Robert Böhm
Research Article | published 09 Feb 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003919

Perceptions of risk of SARS-CoV-2 transmission in social and educational activities by infectious diseases and general pediatric healthcare providers, a pre-vaccine risk perception cross-sectional survey

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

 

Research Article
Perceptions of risk of SARS-CoV-2 transmission in social and educational activities by infectious diseases and general pediatric healthcare providers, a pre-vaccine risk perception cross-sectional survey
Andrew B. Janowski, Philip M. Polgreen, Susan E. Beekmann, Jason G. Newland
Research Article | published 11 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263767

Factors affecting intention to take COVID-19 vaccine among Pakistani University Students

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

 

Factors affecting intention to take COVID-19 vaccine among Pakistani University Students
Mosharop Hossian, Md Abdullah Saeed Khan, Anum Nazir, Mohammad Hayatun Nabi, Mehedi Hasan, Ramisha Maliha, Mohammad Ali Hossain, Md Utba Rashid, Nizwa Itrat, Mohammad Delwer Hossain Hawlader
Research Article | published 11 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0262305

Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

 

Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population
Yasmin Maor, Shaked Caspi
Research Article | published 11 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0255495

Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

 

Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic
Karandeep Singh, Gabriel Lima, Meeyoung Cha, Chiyoung Cha, Juhi Kulshrestha, Yong-Yeol Ahn, Onur Varol
Research Article | published 09 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263381

The impact of risk perceptions and belief in conspiracy theories on COVID-19 pandemic-related behaviours

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

 

The impact of risk perceptions and belief in conspiracy theories on COVID-19 pandemic-related behaviours
Jack P. Hughes, Alexandros Efstratiou, Sara R. Komer, Lilli A. Baxter, Milica Vasiljevic, Ana C. Leite
Research Article | published 08 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263716

Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave

PNAS – Proceedings of the National Academy of Sciences of the United States
January 11, 2022; vol. 119 no. 3
https://www.pnas.org/content/119/3

 

Biophysics and Computational Biology
Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave
Nathaniel Hupert, Daniela Marín-Hernández, Bo Gao, Ricardo Águas, and Douglas F. Nixon
PNAS January 18, 2022 119 (3) e2025448119; https://doi.org/10.1073/pnas.2025448119

Politicians polarize and experts depolarize public support for COVID-19 management policies across countries

PNAS – Proceedings of the National Academy of Sciences of the United States
January 11, 2022; vol. 119 no. 3
https://www.pnas.org/content/119/3

 

Psychological and Cognitive Sciences
Open Access
Politicians polarize and experts depolarize public support for COVID-19 management policies across countries
Alexandra Flores, Jennifer C. Cole, Stephan Dickert, Kimin Eom, Gabriela M. Jiga-Boy, Tehila Kogut, Riley Loria, Marcus Mayorga, Eric J. Pedersen, Beatriz Pereira, Enrico Rubaltelli, David K. Sherman, Paul Slovic, Daniel Västfjäll, and Leaf Van Boven
PNAS January 18, 2022 119 (3) e2117543119; https://doi.org/10.1073/pnas.2117543119